SCHEMBL24136459

SCHEMBL24136459

CS(=O)(=O)O[C@@H]1CC2CN(C(=O)OCc3ccccc3)C[C@@H]2C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F13A1 P00488 3/20 0.49
TGM2 P21980 3/20 0.49
TGM1 P22735 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
CYP2C19 P33261 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HTR2C P28335 1/20 0.44
PDE4B Q07343 2/20 0.44
GAA P10253 1/20 0.43
TSHR P16473 1/20 0.43
MMP1 P03956 1/20 0.42
MMP3 P08254 1/20 0.42
MMP7 P09237 1/20 0.42
MMP9 P14780 1/20 0.42
MMP13 P45452 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17633253 1.00 F13A1 (0.49) F13A1TGM2TGM1SMN1; SMN2NPC1
SCHEMBL20983428 1.00 F13A1 (0.49) F13A1TGM2TGM1SMN1; SMN2NPC1
SCHEMBL17633251 1.00 F13A1 (0.49) F13A1TGM2TGM1SMN1; SMN2NPC1
SCHEMBL9873300 1.00 F13A1 (0.49) F13A1TGM2TGM1SMN1; SMN2NPC1
SCHEMBL17633250 1.00 F13A1 (0.49) F13A1TGM2TGM1SMN1; SMN2NPC1
SCHEMBL18592896 0.91 SMN1; SMN2 (0.53) F13A1TGM2TGM1SMN1; SMN2NPC1
SCHEMBL13567846 0.85 SMN1; SMN2 (0.52) F13A1TGM2TGM1SMN1; SMN2NPC1
SCHEMBL3628114 0.84 SMN1; SMN2 (0.60) F13A1TGM2TGM1SMN1; SMN2NPC1
SCHEMBL12836007 0.84 SMN1; SMN2 (0.60) F13A1TGM2TGM1SMN1; SMN2NPC1
SCHEMBL31459972 0.84 F13A1 (0.48) F13A1TGM2TGM1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3683207-B1 N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOSTERIC MODULATORS OF NR2B CADENT THERAPEUTICS INC (US) 2021-12-29 EP disclosed